image_alt_text
6

Agnes Yeboah, Ph.D.

AIMBE College of Fellows Class of 2022
For outstanding contributions leading the development and regulatory strategies for commercializing life-saving biologics and cell therapies.

Dr. Agnes Yeboah Elected to the 2022 Class of the AIMBE College of Fellows

Via AIMBE | February 18, 2022

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Agnes Yeboah, Ph.D., Executive Director, Global Regulatory Affairs – CMC Biologics and Cell Therapy, Bristol Myers Squibb to its College of Fellows. Dr. Yeboah was nominated, reviewed, and elected by peers and members of the AIMBE College of Fellows for outstanding contributions leading the development and regulatory strategies for commercializing life-saving biologics and cell therapies.

The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Nobel Prize, the Presidential Medal of Science and the Presidential Medal of Technology and Innovation, and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences… Continue reading.

...